Compounding order under Section 441 of the Companies Act, 2013 for violation of Section 129 of the Companies Act, 2013 in the matter of M/s.Sun Pharmaceutical Industries Limited
| i i File No. RD (NVVR)/441/007/2024/L,02 SRN GNL-1 F98858038 Dated: 19.09.2024 BEFORE THE REGIONAL DIRECTOR (NWR), AHMEDABAD MINISTRY OF CORPORATE AFFAIRS IN THE MATTER OF :- SECTION 441 OF THE COMPANIES ACT, 2013 AND SECTION 129 OF THE .COMPANIES ACT, 2013 IN THE MATTER OF :-
- M/s. Sun Pharmaceutical Industries Limited -(Applicant No.1)
- Mr. Dilip Shantilal Shanghvi, Chairman & MD -(Applicant No.2)
- Mr. Sailesh Trambaklal Desai, Ex-WTD -(Applicant No.3)
- Mr. Sudhir Vrundavandas Valia, Director & Ex-WTD -(Applicant No.4)
- Mr. Uday Baldota, Ex-CFO -(Applicant No.5) FINAL ORDER pate: 1 0 DEC 2024
Compounding application received from: . M/s. Sun Pharmaceutical Industries Limited -(Applicant No.1) . Mr. Dilip Shantilal Shanghvi, Chairman & MD -(Applicant No.2) . Mr. Sailesh Trambaklal Desai, Ex-WTD -(Applicant No.3) . Mr. Sudhir Vrundavandas Valia, Director & Ex-WTD -(Applicant No.4) . Mr. Uday Baldota, Ex-CFO -(Applicant No.5) under Section 441 of the Companies Act, 2013. . Violation-Details and nature of the violation: For non-disclosure of the facts as required under AS-18 read with Sec. 129 of the Companies Act, 2013 during the F.Y 2013-14 to 2017-18. 3. Reference of interim order: No. RD(NWR)/441/007/2024 dated 26.11.2024, 4. Compounding fee levied: F.Y.2013-14 to 2017-18 Sr. | Name and Designation of the | Provision violated | Compounding fee No. | Applicant for the year. payable by the applicant (In Rs.) 1. | Mr. Dilip Shantilal Shanghvi, 2013-14 to0 2017-18 3,75,000/- Chairman & MD 2. | Mr. Sailesh Trambaklal Desai, | 2013-14 to 2017-18 3,75,000/- Ex-WTD 3. | Mr. Sudhir Vrundavandas 2013-14 t0 2017-18 3,75,000/- Valia, Director & Ex-WTD 4. | Mr. Uday Baldota, Ex-CFO 2013-14 t0 2017-18 3,75,000/- Total 15,00,000/- 5. Payment of Compounding fee: Sr. | Name and Designation of Receipt details Amount paid No. | the Applicant (In Rs.) 1. | Mr. Dilip Shantilal Shanghvi, | X87655106 3,75,000/- Chairman & MD Dated 06.12.2024 | 2. | Mr. Sailesh Trambaklal Desai, | X87655486 3,75,000/- Ex-WTD Dated 06.12.2024 3. | Mr. Sudhir Vrundavandas X87654604 3,75,000/- Valia, Director & Ex-WTD Dated 06.12.2024 4. Mr. Uday Baldota, Ex-CFO X87654612 3,75,000/- Dated 06.12.2024 Total 15,00,000/- 1|Page
V { 6. Considering the facts and circumstances described in interim order dated 26.11.2024 and on account of payment of compounding fee, the compounding application bearing SRN F98858038 (GNL-1) is hereby allowed. 7. Company is hereby directed to file this compounding order in prescribed E-form INC-28 with the jurisdictional ROC under the provisions of Section 441(3)(d) of the Companies Act, 2013, Dated this [Jgay of December, 2024 (G.C. YADAY) Regional Director (NWR)(I/C) Ahmedabad To (\IAV[/S. Sun Pharmaceutical Industries Limited SPARC, Tandzlja, Vadodara, Gujarat-390012. Mr. Dilip Shantilal Shanghvi Tirth, New India Society No. 17, 12" Road, JVPD, Vile Parle West, Mumbai, Maharashtra - 400049. Mr. Shailesh Trambaklal Desai Aditya A Wing, 10™ FLR, Gulmohor X RD No. 7 JVPD Scheme, Vile Parle West, Mumbai, Maharashtra — 400049. Mr. Sudhir Vrundavandas Valia 801, 8" Floor, Aalap Building, 173 Sir Bhalchandra Road, Opp. Hindu Colony, Dadar(East), Mumbai, Maharashtra - 400014. Uday Baldota X-601, Callaliy, Nahar Amrit Shakti, Chandivali, Mumbai, Maharashtra-400072. 6. Registrar of Companies, Ahmedabad, Gujarat Master File 8. Office Copy
(Kamal Harjani) Joint Director For Regional Director 2|Page
Verbatim extracted text (OCR/PDF). Older scans and tables may show extraction artifacts — verify against the original for anything you act on.
No analysis has been generated for this document yet.